Projects funded by the NCN
Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth
2023/50/E/NZ7/00501
Keywords:
drug design enzyme inhibitors one-carbon metabolism anticancer therapeutics
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ1_4: Structural biology
- NZ1_2: Biochemistry
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Chemii Bioorganicznej Polskiej Akademii Nauk
woj. wielkopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: SONATA BIS 13 - announced on 2023-06-19
Amount awarded: 4 098 956 PLN
Project start date (Y-m-d): 2024-04-12
Project end date (Y-m-d): 2029-04-11
Project duration:: 60 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.